Alejandro Alcala - Nov 7, 2022 Form 4 Insider Report for Crane Holdings, Co. (CXT)

Signature
Attorney In Fact, Anthony M. D'Iorio
Stock symbol
CXT
Transactions as of
Nov 7, 2022
Transactions value $
-$1,109,776
Form type
4
Date filed
11/9/2022, 04:04 PM
Previous filing
Aug 22, 2022
Next filing
Jan 26, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CXT CRANE HOLDINGS, CO. COMMON, PAR VALUE $1.00 Options Exercise $696K +10.7K +48.43% $64.78 32.9K Nov 7, 2022 Direct F1
transaction CXT CRANE HOLDINGS, CO. COMMON, PAR VALUE $1.00 Options Exercise $872K +14.9K +45.29% $58.47 47.8K Nov 7, 2022 Direct F2
transaction CXT CRANE HOLDINGS, CO. COMMON, PAR VALUE $1.00 Sale -$2.68M -25.6K -53.63% $104.38 22.2K Nov 7, 2022 Direct F3
holding CXT CRANE HOLDINGS, CO. COMMON, PAR VALUE $1.00 283 Nov 7, 2022 401 (k)

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CXT Employee Stock Option (Right to Buy) Options Exercise $0 -10.7K -100% $0.00* 0 Nov 7, 2022 CRANE HOLDINGS, CO. COMMON, PAR VALUE $1.00 10.7K $64.78 Direct F4
transaction CXT Employee Stock Option (Right to Buy) Options Exercise $0 -14.9K -100% $0.00* 0 Nov 7, 2022 CRANE HOLDINGS, CO. COMMON, PAR VALUE $1.00 14.9K $58.47 Direct F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Mr. Alcala exercised 10,740 stock options granted 1/27/2014 and set to expire 1/27/2024 priced at $64.78 and sold at a weighted average price of $104.38.
F2 Mr. Alcala exercised 14,909 stock options granted 1/26/2015 and set to expire 1/26/2025 priced at $58.47 and sold at a weighted average price of $104.38.
F3 Weighted average price at which shares were sold at prices ranging from $103.97 to $104.79. The reporting person undertakes to provide, upon request of the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
F4 The options were granted 1/27/2014 with a ten-year term and vested 25% each year over four years.
F5 The options were granted 1/26/2015 with a ten-year term and vested 25% each year over four years.